7.8 C
New York
Thursday, April 18, 2024

Benchmark Initiates Applied DNA Sciences With Speculative Buy

Courtesy of Benzinga.

Related APDN
Applied DNA Sciences to Present at the Marcum MicroCap Conference on May 28 in New York City
Applied DNA Sciences, Inc. Announces Closing of $12.0M Public Offering and Partial Exercise of Over-Allotment Option

Analysts at Benchmark initiated coverage on Applied DNA Sciences Inc (NASDAQ: APDN) with a Speculative Buy rating.

The target price for Applied DNA Sciences is set to $5.

Applied DNA Sciences shares have dropped 61.36 percent over the past 52 weeks, while the S&P 500 index has surged 11.87 percent in the same period.

Applied DNA Sciences’ shares rose 2.41 percent to close at $2.55 on Friday.

Latest Ratings for APDN

Date Firm Action From To
May 2015 Benchmark Initiates Coverage on Sell

View More Analyst Ratings for APDN
View the Latest Analyst Ratings

Posted-In: BenchmarkInitiation Analyst Ratings

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,354FansLike
396,312FollowersFollow
2,290SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x